Zobrazeno 1 - 10
of 345
pro vyhledávání: '"Stijn E Verleden"'
Autor:
Jie Jia, Thomas M Conlon, Rim SJ Sarker, Demet Taşdemir, Natalia F Smirnova, Barkha Srivastava, Stijn E Verleden, Gizem Güneş, Xiao Wu, Cornelia Prehn, Jiaqi Gao, Katharina Heinzelmann, Jutta Lintelmann, Martin Irmler, Stefan Pfeiffer, Michael Schloter, Ralf Zimmermann, Martin Hrabé de Angelis, Johannes Beckers, Jerzy Adamski, Hasan Bayram, Oliver Eickelberg, Ali Önder Yildirim
Publikováno v:
EMBO Molecular Medicine, Vol 10, Iss 5, Pp 1-17 (2018)
Abstract The development of chronic obstructive pulmonary disease (COPD) pathogenesis remains unclear, but emerging evidence supports a crucial role for inducible bronchus‐associated lymphoid tissue (iBALT) in disease progression. Mechanisms underl
Externí odkaz:
https://doaj.org/article/97fa922cf1de46cda5b806cfa389d804
Autor:
Annelore Sacreas, Joshua Y C Yang, Bart M Vanaudenaerde, Tara K Sigdel, Juliane M Liberto, Izabella Damm, Geert M Verleden, Robin Vos, Stijn E Verleden, Minnie M Sarwal
Publikováno v:
PLoS ONE, Vol 13, Iss 10, p e0205107 (2018)
RATIONALE:Recent studies suggest that similar injury mechanisms are in place across different solid organ transplants, resulting in the identification of a common rejection module (CRM), consisting of 11 genes that are overexpressed during acute and,
Externí odkaz:
https://doaj.org/article/9b70b6d308e145e5bf64af41a026c54b
Autor:
David Ruttens, Stijn E Verleden, Heleen Demeyer, Dirk E Van Raemdonck, Jonas Yserbyt, Lieven J Dupont, Bart M Vanaudenaerde, Robin Vos, Geert M Verleden
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0193564 (2018)
Bronchiolitis obliterans syndrome (BOS) remains the major problem which precludes long-term survival after lung transplantation. Previously, an open label pilot study from our group demonstrated a possible beneficial effect of montelukast in progress
Externí odkaz:
https://doaj.org/article/46f5b15056e94de4ae0daa98bb8212f6
Autor:
Maximilian Ackermann, Jan C. Kamp, Christopher Werlein, Claire L. Walsh, Helge Stark, Verena Prade, Rambabu Surabattula, Willi L. Wagner, Catherine Disney, Andrew J. Bodey, Thomas Illig, Diana J. Leeming, Morten A. Karsdal, Alexandar Tzankov, Peter Boor, Mark P. Kühnel, Florian P. Länger, Stijn E. Verleden, Hans M. Kvasnicka, Hans H. Kreipe, Axel Haverich, Stephen M. Black, Axel Walch, Paul Tafforeau, Peter D. Lee, Marius M. Hoeper, Tobias Welte, Benjamin Seeliger, Sascha David, Detlef Schuppan, Steven J. Mentzer, Danny D. Jonigk
Publikováno v:
EBioMedicine, Vol 85, Iss , Pp 104296- (2022)
Summary: Background: COVID-19 is characterized by a heterogeneous clinical presentation, ranging from mild symptoms to severe courses of disease. 9–20% of hospitalized patients with severe lung disease die from COVID-19 and a substantial number of
Externí odkaz:
https://doaj.org/article/b4f5f451eaf04dc4b18d8490c6c059a3
Autor:
Jakob Reichmann, Stijn E Verleden, Mark Kühnel, Jan C Kamp, Christopher Werlein, Lavinia Neubert, Jan-Hendrik Müller, Thanh Quynh Bui, Maximilian Ackermann, Danny Jonigk, Tim Salditt
Publikováno v:
Physics in medicine & biology
As the central organ of the respiratory system, the human lung is responsible for supplying oxygen to the blood, which reaches the erythrocytes by diffusion through the alveolar walls and is then distributed throughout the body. By exploiting the dif
Autor:
Sundaresh Ram, Stijn E Verleden, Madhav Kumar, Alexander J. Bell, Ravi Pal, Sofie Ordies, Arno Vanstapel, Adriana Dubbeldam, Robin Vos, Stefanie Galban, Laurens J. Ceulemans, Anna E. Frick, Dirk E. Van Raemdonck, Johny Verschakelen, Bart M. Vanaudenaerde, Geert M. Verleden, Vibha N Lama, Arne P. Neyrinck, Craig J. Galban
Publikováno v:
medRxiv
BackgroundAssessment and selection of donor lungs remains largely subjective and experience based. Criteria to accept or decline lungs are poorly standardized and are not compliant with the current donor pool. Using ex vivo CT images, we investigated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1eb9599c1e7afb23db89ea0fb06884d
https://doi.org/10.1101/2023.03.28.23287705
https://doi.org/10.1101/2023.03.28.23287705
Autor:
Stijn E. Verleden, Arno Vanstapel, Joseph Jacob, Tinne Goos, Jeroen Hendriks, Laurens J. Ceulemans, Dirk E. Van Raemdonck, Laurens De Sadeleer, Robin Vos, Johanna M. Kwakkel-van Erp, Arne P. Neyrinck, Geert M. Verleden, Matthieu N. Boone, Wim Janssens, Els Wauters, Birgit Weynand, Danny D. Jonigk, Johny Verschakelen, Wim A. Wuyts
Publikováno v:
RADIOLOGY
Radiology
Radiology
Background: Interstitial lung abnormalities (ILAs) reflect imaging features on lung CT scans that are compatible with (early) interstitial lung disease. Despite accumulating evidence regarding the incidence, risk factors, and prognosis of ILAs, the h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::606bbd30405b67e654a44e7a42e1c2b1
https://hdl.handle.net/1854/LU-01GTJ36HQEQS82H831A63PN26D
https://hdl.handle.net/1854/LU-01GTJ36HQEQS82H831A63PN26D
Autor:
Stijn E. Verleden, Jeroen M.H. Hendriks, Patrick Lauwers, Suresh Krishan Yogeswaran, Veronique Verplancke, Johanna M. Kwakkel-Van-Erp
Publikováno v:
Transplantation
Chronic lung allograft dysfunction (CLAD) remains a major hurdle impairing lung transplant outcome. Parallel to the better clinical identification and characterization of CLAD and CLAD phenotypes, there is an increasing urge to find adequate biomarke
Autor:
Birger Tielemans, Kaat Dekoster, Stijn E. Verleden, Stefan Sawall, Bartosz Leszczyński, Kjell Laperre, Arno Vanstapel, Johny Verschakelen, Marc Kachelriess, Erik Verbeken, Jim Swoger, Greetje Vande Velde
Publikováno v:
Diagnostics, Vol 10, Iss 9, p 636 (2020)
Lung diseases such as fibrosis, asthma, cystic fibrosis, infection and cancer are life-threatening conditions that slowly deteriorate quality of life and for which our diagnostic power is high, but our knowledge on etiology and/or effective treatment
Externí odkaz:
https://doaj.org/article/4fbeb151cc7443abb9c76219433d7976
Autor:
Geert Verleden, Stijn E. Verleden
Publikováno v:
Current opinion in organ transplantation
Purpose of review Chronic lung allograft dysfunction (CLAD) remains a major barrier preventing long-term survival following lung transplantation. As our clinical knowledge regarding its definition and presentation has significantly improved over the